Related MeSH Hierarchy (6)
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Germ Cell and Embryonal » Neuroectodermal Tumors » Neoplasms, Neuroepithelial » Glioma » Medulloblastoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Germ Cell and Embryonal » Neuroectodermal Tumors » Neoplasms, Neuroepithelial » Neuroectodermal Tumors, Primitive » Medulloblastoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Neoplasms, Neuroepithelial » Glioma » Medulloblastoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Neoplasms, Neuroepithelial » Neuroectodermal Tumors, Primitive » Medulloblastoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Nerve Tissue » Neuroectodermal Tumors » Neoplasms, Neuroepithelial » Glioma » Medulloblastoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Nerve Tissue » Neuroectodermal Tumors » Neoplasms, Neuroepithelial » Neuroectodermal Tumors, Primitive » Medulloblastoma
Description
A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1) MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (7)
Phase 2 Indicated Drugs (52)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (13)
Organization Involved with Phase 2 Indications (67)
Centre Georges Francois Leclerc
Centre Hospitalier Universitaire de Nīmes
Children's Cancer and Leukaemia Group
European Organisation for Research and Treatment of Cancer
Florida International University
National Institute of Neurological Disorders and Stroke (NINDS)
National Institutes of Health (NIH)
Neuroblastoma and Medulloblastoma Translational Research Consortium
Pediatric Brain Tumor Consortium
Royal Liverpool & Broadgreen University Hospitals NHS Truts
Royal Marsden Hospital NHS Trust
Organization Involved with Phase 1 Indications (35)
American Lebanese Syrian Associated Charities
Annias Immunotherapeutics, Inc.
Cannonball Kids' Cancer Foundation
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Medical University of South Carolina
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
